Your browser doesn't support javascript.
loading
Formulation and dermal delivery of a new active pharmaceutical ingredient in an in vitro wound model for the treatment of chronic ulcers.
Thormann, Ursula; Marti, Selina; Lensmith, Elizabeth; Lanz, Michael; Herzig, Susanne; Naef, Reto; Imanidis, Georgios.
Afiliación
  • Thormann U; School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland.
  • Marti S; School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland.
  • Lensmith E; School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland.
  • Lanz M; School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland.
  • Herzig S; School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland.
  • Naef R; Topadur Pharma AG, Schlieren, Switzerland.
  • Imanidis G; School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland. Electronic address: georgios.imanidis@unibas.ch.
Eur J Pharm Biopharm ; 202: 114373, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38906230
ABSTRACT
The aim of this study was to investigate dermal delivery of the new active pharmaceutical ingredient (API) TOP-N53 into diabetic foot ulcer using an in vitro wound model consisting of pig ear dermis and elucidate the impact of drug formulation and wound dressing taking into consideration clinical relevance in the home care setting and possible bacterial infection. Different formulation approaches for the poorly water-soluble API including colloidal solubilization, drug micro-suspension and cosolvent addition were investigated; moreover, the effect of (micro-)viscosity of hydrogels used as primary wound dressing on delivery was assessed. Addition of Transcutol® P as cosolvent to water improved solubility and was significantly superior to all other approaches providing a sustained three-day delivery that reached therapeutic drug levels in the tissue. Solubilization in micelles or liposomes, on the contrary, did not boost delivery while micro-suspensions exhibited sedimentation on the tissue surface. Microbial contamination was responsible for considerable metabolism of the drug leading to tissue penetration of metabolites which may be relevant for therapeutic effect. Use of hydrogels under semi-occlusive conditions significantly reduced drug delivery in a viscosity-dependent fashion. Micro-rheologic analysis of the gels using diffusive wave spectroscopy confirmed the restricted diffusion of drug particles in the gel lattice which correlated with the obtained tissue delivery results. Hence, the advantages of hydrogel dressings from the applicatory characteristic point of view must be weighed against their adverse effect on drug delivery. The employed in vitro wound model was useful for the assessment of drug delivery and the development of a drug therapy concept for chronic diabetic foot ulcer. Mechanistic insights about formulation and dressing performance may be applied to drug delivery in other skin conditions such as digital ulcer.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cicatrización de Heridas / Pie Diabético / Hidrogeles Límite: Animals Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cicatrización de Heridas / Pie Diabético / Hidrogeles Límite: Animals Idioma: En Revista: Eur J Pharm Biopharm Asunto de la revista: FARMACIA / FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Países Bajos